Pre-Diabetes Clinical Trial
Official title:
TEEN HEED: An Adolescent Peer Led Diabetes Prevention Intervention
Verified date | November 2019 |
Source | Icahn School of Medicine at Mount Sinai |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The number of youth with type 2 diabetes is predicted to quadruple by 2050, with a disproportionate increase among minority youth. The research proposed in this Career Development Award will use community-based participatory research methodology as well as novel strategies (peer education and mobile health technologies) to design, implement and evaluate a diabetes prevention intervention for at-risk ethnic minority youth in an urban community with high disease burden.
Status | Completed |
Enrollment | 90 |
Est. completion date | August 24, 2019 |
Est. primary completion date | August 24, 2019 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 13 Years to 19 Years |
Eligibility |
Inclusion Criteria for pre-diabetes screening: - Adolescents ages 13-19 years of age - English speaking - Residents of East Harlem or members of an East Harlem Institution. Membership in an East Harlem institution includes the following: 1. attending a school in East Harlem 2. attending an after school or recreational activity in East Harlem 3. receiving health care in East Harlem Proof of address or membership in an East Harlem institution will not be asked. - At risk for diabetes (overweight/obese based on measured BMI percentile and with either a parent or grandparent with type 2 diabetes) - No plans to relocate from New York City in the next year Note: additional inclusion criteria for participation in workshops include diagnosis of pre-diabetes based on oral glucose tolerance test Exclusion Criteria for pre-diabetes screening: - <13 or >19 years of age - Previous diagnosis of diabetes - BMI percentile <85th percentile for age and gender based on Centers for Disease Control and Prevention definition - Currently pregnant - Speaking a language other than English - On medications that may raise or lower blood sugar - Plans to relocate from New York City within one year of enrollment- Note: additional exclusion criteria for participation in workshops include fingerstick glucoses outside the pre-diabetes range during oral glucose tolerance testing and any cognitive or physical impairment that would preclude comprehension of the group educational program |
Country | Name | City | State |
---|---|---|---|
United States | Icahn School of Medicine at Mount Sinai | New York | New York |
Lead Sponsor | Collaborator |
---|---|
Icahn School of Medicine at Mount Sinai | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in body mass index (BMI) | Change in BMI at post-intervention (approximately 3 months) as compared to baseline | Baseline and 3 months | |
Primary | Change in BMI | Change in BMI at 1 year as compared to baseline | Baseline and 1 year | |
Secondary | Change in fasting blood glucose levels | Change in fasting blood glucose levels at post-intervention (approximately 3 months) as compared to baseline | Baseline and 3 months | |
Secondary | Change in fasting blood glucose levels | Change in fasting blood glucose levels at 1 year as compared to baseline | Baseline and 1 year | |
Secondary | Change in post prandial blood glucose level | Change in post prandial blood glucose level at post-intervention (approximately 3 months) as compared to baseline | Baseline and 3 months | |
Secondary | Change in post prandial blood glucose level | Change in post prandial blood glucose level at 1 year as compared to baseline | Baseline and 1 year | |
Secondary | Change in blood pressure | Change in blood pressure at post-intervention (approximately 3 months) as compared to baseline | Baseline and 3 months | |
Secondary | Change in blood pressure | Change in blood pressure at 1 year as compared to baseline | Baseline and 1 year | |
Secondary | Change in percent body fat | Change in percent body fat at post-intervention (approximately 3 months) as compared to baseline | Baseline and 3 months | |
Secondary | Change in percent body fat | Change in percent body fat at 1 year as compared to baseline | Baseline and 1 year | |
Secondary | Change in waist circumference | Change in waist circumference at post-intervention (approximately 3 months) as compared to baseline | Baseline and 3 months | |
Secondary | Change in waist circumference | Change in waist circumference at 1 year as compared to baseline | Baseline and 1 year | |
Secondary | Change in knowledge, attitudes, beliefs and behaviors related to diabetes and weight loss | Change in knowledge, attitudes, beliefs and behaviors (from the TEEN HEED survey) at post-intervention (approximately 3 months) as compared to baseline | Baseline and 3 months | |
Secondary | Change in knowledge, attitudes, beliefs and behaviors related to diabetes and weight loss | Change in knowledge, attitudes, beliefs and behaviors (from the TEEN HEED survey) at 1 year as compared to baseline | Baseline and 1 year |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
Enrolling by invitation |
NCT05367024 -
Broccoli Effect on Glycated Haemoglobin (HbA1c)
|
N/A | |
Completed |
NCT02933424 -
Project Plant Protein: the P3 Study in Humans
|
N/A | |
Withdrawn |
NCT02400450 -
Designer Functional Foods on Parameters of Metabolic and Vascular in Prediabetes
|
N/A | |
Completed |
NCT02656212 -
Early Phase Pre-Clinical and Initial Clinical Research on Epicatechin (Part 2)
|
Phase 1 | |
Completed |
NCT02330276 -
Early Phase Pre-Clinical and Initial Clinical Research on Epicatechin
|
Phase 1 | |
Completed |
NCT01488279 -
Effect of Sitagliptin on Short-Term Metabolic Dysregulation of Oral Glucocorticoid Therapy
|
N/A | |
Completed |
NCT00831129 -
A Study for Pre-diabetic Patients With Cholesterol Lowering Drugs
|
Phase 2/Phase 3 | |
Completed |
NCT00536250 -
Study to Investigate the Pathophysiology of Type 2 Diabetes in Youth
|
N/A | |
Recruiting |
NCT05563090 -
Investigating the Syndrome Differentiation of Diabetic and Pre-diabetic Using Digitalized TCM Diagnostic Tools
|
||
Active, not recruiting |
NCT04991142 -
Models of Nutrition From Continuous Glucose Monitors
|
||
Completed |
NCT02759055 -
Pre-Diabetes Cardiovascular (CV) Care (Pre-Diabetes Wizard)
|
N/A | |
Completed |
NCT00775684 -
Effect of Exenatide, Sitagliptin or Glimepiride on Functional ß -Cell Mass
|
N/A | |
Completed |
NCT03695913 -
Continuous Glucose Monitoring (CGM) With a Low Carbohydrate Diet to Reduce Weight in Patients With Pre-Diabetes
|
N/A | |
Completed |
NCT04051008 -
CTSI Pilot: Improving Adherence to Diabetic Diet
|
N/A | |
Recruiting |
NCT04897945 -
A Shared Decision Making Intervention for Diabetes Prevention in Women With a History of Gestational Diabetes Mellitus
|
N/A | |
Not yet recruiting |
NCT04442451 -
Mechanisms of Fatigability With Diabetes
|
N/A | |
Not yet recruiting |
NCT05925933 -
High Protein Diet on Transcriptomic, Metabolomics, Hepatic and Pancreatic Fat Anatomy and Physiology in Asian Indians With Pre-diabetes
|
N/A | |
Active, not recruiting |
NCT05654051 -
The SLIM LIVER Study
|
Phase 2 | |
Completed |
NCT02919397 -
Motivational Instant Messaging and E-diabetes Prevention Programme for High Risk of Type 2 Diabetes
|
N/A |